LCS-SeNPs alleviate DSS-induced colitis in mice, probably because of its combined favorable effects, which inhibits pro-inflammatory cytokines (IL-6 and TNF-α) and the production of oxidative index MDA, promotes the production of GSH-Px resulting in the restoration of intestinal permeability. Here, IL6 is linked to colitis.